Advertisement

Topics

Companies Related to "First Time in Human Study of Intravenous Interleukin-18 Antibody" [Most Relevant Company Matches] RSS

19:54 EST 11th December 2018 | BioPortfolio

Here are the most relevant search results for "First Time in Human Study of Intravenous Interleukin-18 Antibody" found in our extensive corporate database of over 50,000 company records.

Showing "First Time Human Study Intravenous Interleukin Antibody" Companies 1–25 of 5,100+

Relevant

Globe Laboratories

Globe Labs manufactures and sells high quality, low cost human therapeutic proteins, human growth hormones, enzymes, research laboratory cytokines, chemokines & their respective inhibitors/antagonists for research and veterinary use. We are also manufacturers of bulk quantities for other pharmaceutical companies worldwide. Globe Labs is proud to have the largest antagonist product list in the worl...


Acceptys, Inc.

Acceptys is a private biotechnology company focused on the development of human antibody therapies in cancer and infectious diseases. The Company's key strength is its ability to directly leverage the power of the human immune system, which has continually evolved with the specific purpose of preserving health. More specifically, Acceptys can capture thousands of antibodies from strategically targ...

Abnova Corporation

Abnova is the world largest monoclonal antibody manufacturer. We have a capacity of generating 500 mouse monoclonal antibodies per month. Rather than the traditional method of monoclonal antibody production, Abnova is taking a genomic/proteomic approach for the antibody development. Our goal is to have at least one antibody to every human expressed gene in human genome. We manufacture all our prod...


Abnova Corporation

Abnova is the world largest monoclonal antibody manufacturer. We have a capacity of generating 500 mouse monoclonal antibodies per month. Rather than the traditional method of monoclonal antibody production, Abnova is taking a genomic/proteomic approach for the antibody development. Our goal is to have at least one antibody to every human expressed gene in human genome. We manufacture all our prod...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its resear...

Antibodies by Design

Antibodies by Design uses proven MorphoSys recombinant antibody technology to provide high quality monoclonal antibodies to its customers in record time. The HuCAL GOLD® library contains over 15 billion unique human antibody genes in Fab format. This wealth and diversity of sequences is coupled with proprietary automated screening techniques and advanced data management systems to quickly identif...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intell...

PharmAbcine Inc.

PharmAbcine is a leading clinical stage biologics company that develops fully human therapeutic antibody (mAb) and next generation multispecific antibody therapeutics based on in-house developed novel platform, DIG-Body, PIG-Body and TIG-Body using innovative discovery technology and excellent human resources for the treatment of human diseases, such as ca...

ebioscience

ebioscience have extensive expertise in antibody development, as well as personal histories of raising industry standards for antibody quality.Researchers worldwide have always been assured that their research funding and time are well-invested in eBioscience antibodies. Time and time again, eBioscience reagents have provided researchers with the consistent, quality data that they expect

KaloBios Pharmaceuticals, Inc.

KaloBios Pharmaceuticals, Inc., a U.S. based, private monoclonal company, uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics. The company has multiple programs that have been in seven Phase 1 or 2 clinical trials in the last few years. KB001 is a PEGylated monoclonal antibody fragmen...

MedImmune

MedImmune Incorporated is a biotechnology company headquartered in Gaithersburg, Maryland with three products on themarket and a diverse product development portfolio. MedImmune is focused on using advances in immunology and other biological sciences to develop important new products that address significant medical needs in areas such as infectious diseases, transplantation medicine, autoimmune ...

Biovation Limited

Biovation is a leading European protein engineering company specialising in antibody and protein engineering, with particular emphasis on antibody-based therapeutics. The Company is focused on the generation of antibodies and proteins which are non-immunogenic in man. The focus for protein therapeutics is the generation of clinically safe and effective molecules which are tolerated by the human im...

Octapharma USA

Headquartered in Lachen, Switzerland, Octapharma is one of the largest plasma products manufacturers in the world and has been committed to patient care and medical innovation for over 25 years. Octapharma's core business is the development, production and sale of high quality human protein therapies from both human plasma and human cell-lines, including immune globulin intravenous (IGIV). In the ...

Medarex

Medarex is an integrated monoclonal antibody-based company with antibody discovery, development and manufacturing capabilities. Utilizing its HuMAb-Mouse(TM) system, Medarex has the ability to make fully-human antibodies in a transgenic mouse whose mouse genes for creating antibodies have been inactivated and replaced by human antibody genes. The Company has entered into ten corporate partnering a...

AvantGen, Inc.

AvantGen, Inc is a privately-held antibody discovery and optimization service provider and a leader in the use of yeast display technology for antibody discovery and optimization. Founded by experts in the creation of antibody discovery and optimization platforms, AvantGen excels in the rapid, cost-effective generation of antibodies for therapeutic, diagno...

Cambridge Antibody Technology

Cambridge Antibody Technology (CAT) is a biopharmaceutical company committed to developing human monoclonal antibody therapeutics to bring improvements to seriously ill patients' lives.CAT has strong financial foundations, good medium term prospects and significant opportunities for growth in the longer term.

Antibody Solutions Inc

Antibody Solutions Inc., based in Mountain View in the San Francisco Bay Area, offers quality antibody development, antibody manufacture and immunoassay development that are optimized for your specific application. We serve biotechnology, diagnostic, and pharmaceutical companies, as well as universities by providing innovative antibody products and services. Antibody Solutions delivers quality by ...

Innova Biosciences

Innova Biosciences is the inventor of the World's easiest to use antibody labeling kits. The DIY Lightning-Link™ kit allows you to label an antibody with minimal hands-on time - less than 30 seconds. Simply add your antibody solution to a tube of Lightning-Link™ mix and the label becomes covalently attached to your antibody in a gentle controlled process. We currently have over 40 available ...

CEL-SCI Corporation CEL-SCI Corporation

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. Its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), is currently being studied in a pivotal Phase 3 clinical trial as a potential neoadjuvant treatment for patients with squamous cell carcinoma of the h...

BioTechNews Denmark

TopoTarget and CuraGen Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for MesotheliomaTopoTarget A/S and CuraGen Corporation announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of mesothelioma. This trial is being sponsored by the National ...

Affitech AS

Affitech A/S is a human antibody medicines company based on modern phage display technology coupled with powerful antibody screening and selection systems. In particular the Company has developed specialized expertise (i) to identify and engineer successful new proprietary human antibodies with improved properties over commercially marketed antibody drugs; and (ii) to isolate effective new ant...

Zebra Biologics Inc.

Zebra’s mission is the commercialization of human therapeutic antibodies derived by a novel approach that allows the generation and selection of both agonist and antagonist antibodies from functional screens using a modified combinatorial library approach. This new approach was developed at The Scripps Research Institute (TSRI), San Diego, in the laboratory ...

Vaccinex, Inc

Vaccinex, Inc. is a biotechnology company engaged in the discovery and development of human antibodies into novel therapeutic drugs to treat a variety of diseases. Our proprietary ACTIVMAB antibody discovery technology allows for the direct selection of high affinity, fully human monoclonal antibodies that would be difficult or impossible to identify using other systems. Unique to this technology ...

Antibody Solutions

Antibody Solutions Inc., based in Palo Alto, California, offers quality antibody development, antibody manufacture and immunoassay development that are optimized for your specific application. We serve biotechnology, diagnostic, and pharmaceutical companies, as well as universities by providing innovative antibody products and services.


More From BioPortfolio on "First Time in Human Study of Intravenous Interleukin-18 Antibody"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks